835 results on '"Crotti, Lia"'
Search Results
2. Current gaps in knowledge in inherited arrhythmia syndromes
3. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study
4. Clinical Management of Brugada Syndrome: Commentary From the Experts
5. Worldwide Survey of COVID-19–Associated Arrhythmias
6. The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
7. Abstract 16660: Precision Diagnosis of Hypertrophic Cardiomyopathy: A New Definition of Inappropriate Hypertrophy
8. Effects of cardiac rehabilitation on cardiopulmonary test parameters in heart failure: A real world experience
9. An International Multicenter Evaluation of Type 5 Long QT Syndrome
10. Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathies
11. Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management
12. Calmodulin, sudden death, and the Folbigg case: genes in court
13. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology
14. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
15. Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis
16. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
17. Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases
18. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management
19. Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.
20. Implantable loop recorders in patients with Brugada syndrome: the BruLoop study
21. Prognostic Value of Multiplexed Assays of Variant Effect and Automated Patch-clamping forKCNH2-LQTS Risk Stratification
22. A Systems Biology Approach to Decipher Genetic Variants in a Canine Model of Sudden Cardiac Death
23. Specific Cardiovascular Diseases and Competitive Sports Participation: Channelopathies
24. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)
25. Genetics of Adult and Fetal Forms of Long QT Syndrome
26. Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population
27. Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’ [International Journal of Cardiology, 2023, 41:180–186]
28. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study
29. Long and Short QT Syndromes
30. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
31. Cardiac Genetic Investigation of Sudden Infant and Early Childhood Death: A Study From Victims to Families
32. Executive Attentional Dyscontrol as a Core Cognitive and Behavioral Feature of Individuals with Obesity and Cardiovascular Disease: A Cross-Sectional Investigation
33. Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry
34. From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
35. Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs
36. Common presentation of rare cardiac diseases: Arrhythmias
37. The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?
38. Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol
39. Neuroimmune crosstalk in the pathophysiology of hypertension
40. Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation
41. Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’ [International Journal of Cardiology, 2023, 41:180–186]
42. [Rationale and significance of the Italian Network for Cardiac Amyloidosis]
43. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca
44. EN-452414-5 VENTRICULAR CONDUCTION IS A MARKER FOR ARRHYTHMIC RISK IN OVERLAP SODIUM CHANNEL DISEASE
45. From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow
46. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
47. Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
48. Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome
49. COVID-19 pandemia and inherited cardiomyopathies and channelopathies: a short term and long term perspective
50. A Systems Biology Approach to Decipher Genetic Variants in a Canine Model of Sudden Cardiac Death
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.